SHANGHAI – Multinational pharmaceutical companies have enjoyed premium pricing in China for years, even after products are no longer protected by patents. But those margins are likely to shrink over t
SHANGHAI – Multinational pharmaceutical companies have enjoyed premium pricing in China for years, even after products are no longer protected by patents. But those margins are likely to shrink over t
In Vitro Diagnostics Acquisitions /In Vitro Diagnostics Abbott Laboratories Inc. Celera Corp. In a four-year deal, Celera Corp. has licensed Abbott Laboratories Inc. exclusive rights to distri